Accessibility Tools
Available In:
Price:
Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity. Tirzepatide is a single peptide that triggers the body’s receptors for GIP and GLP-1, two natural incretin hormones.
The usual starting dose for Tirzepatide is 2.5 mg once weekly for 4 weeks. After the first 4 weeks, you may increase the dose by 2.5 mg increments every 4 weeks until the desired goal is reached. Monitor weight loss and side effects.
GIP has decreased food intake and increased energy expenditure, resulting in weight reductions. Combined with a GLP-1 receptor agonist, it has a more significant effect on glucose and body weight effects.
See how to inject GLP1 here.
OWL’s intention is to surpass “normal” in favor of OPTIMAL. This is the guiding principle of ONLINE WELLNESS LEADERS. Our OWL physicians are the key to our success. That’s what truly differentiates OWL from other online wellness companies and prescription based competitors.
info@owltelemedicine.com
(833) OWL-DOCS
© 2024 Online Wellness Leaders (OWL) is a telemedicine company offering virtual consultations with a doctor, whereby OWL administers prescription medications that are sent right to you in the State of Florida. Through the OWL platform, individuals may receive a remote diagnosis and treatment for health and primary care. OWL operates as a LLC registered in Delaware with Foreign Corporation Status in the State of FL and works with board certified physicians located throughout the country to provide professional services.
This website and any materials associated with OWL is operated by Online Wellness Leaders LLC with a registered office in Boca Raton FL 33428, United States of America. You agree to the Terms of Use and Privacy Policy when interacting with the website in any way.
